1st Podcast Nov 16th We are excited to finally announce the LAUNCH DATE of our upcoming podcast series....Diagnostics: Beyond the Lab!
On this podcast we will feature guests from the scientific and health industry discussing innovations in their respective fields. Tune in to our #FIRST EPISODE of the series on 16th November, 2022!
To learn more about #Microbix, visit us at: https://lnkd.in/d5Pyd2kV
For details, #contactus at: bit.ly/3Bs4nts
#Podcast #Diagnostics #BeyondtheLab #Biotechnology #Microbix
Meet one of our first guests on our 1st Episode of Diagnostics: Beyond the Lab, Larry Vaughan!
Larry holds a bachelor's degree in Genetics and a Ph.D. in Molecular Microbiology, both from Trinity College Dublin. He began his career in vet vaccines, leading a molecular development team at BioResearch Ireland, based on the Trinity campus. He moved his career to the US in 1998, joining Corning’s Life Sciences Division, developing products for Pharma research. His desire to return to infectious disease research led him to join Digene Corporation, the first HPV diagnostics company, in 2006.
After the company was acquired by QIAGEN, he moved to his current company, BD (Becton, Dickinson and Company), to head up their R&D assay development group. This group developed the BD Onclarity™ HPV Assay that gained FDA approval in 2018 and additional approval for extended genotyping in 2020. He moved to Medical Affairs in 2019, as a Director of Scientific Affairs.